Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
multiple sclerosis
Pharma
Roche doubles down with subcutaneous FDA nod for MS star Ocrevus
The day after Roche gained an FDA approval for its subcutaneous version of Tecentriq, it also scored with a U.S. nod for its injected Ocrevus.
Kevin Dunleavy
Sep 13, 2024 1:50pm
Merz to expand and hunt for more deals after closing Inbrija buy
Jul 11, 2024 4:08pm
Sponsored
Is treatment for multiple sclerosis about to change fundamentally?
Sep 23, 2024 9:00am
Roche touts near-complete MS suppression for injectable Ocrevus
Apr 17, 2024 11:00am
BMS' Zeposia comes up short in Crohn's disease study
Mar 29, 2024 8:15am
Novartis-backed MS network picks Seqster for data sharing push
Mar 21, 2024 6:00am
